Clinical Trials · NCT07195500

Clinical Application of Somatostatin Receptor and Norepinephrine Transporter Targeted Imaging for Diagnosis and Staging of Neuroblastoma and Pheochromocytoma/Paraganglioma

Phase
N/A
Recruitment status
Recruiting
Sponsor
Nanjing First Hospital, Nanjing Medical University
Enrollment
30
Start date
Dec 2024
Locations
1 site, China
Primary endpoint
SUVmax
View Octreotide compound reference